Obermatt
See Similar Stocks →

Dong-A ST

KSC:170900 · KR7170900005
PharmaceuticalsSmall

360

39
Profit price100
Owner Earnings Yield1
Dividend Yield1
Price/Sales78
EV / Gross Profit73
Price/Book70
Return on Capital59
Cash Return on Capital57
Return on Equity54
EBIT Margin45
Gross Profitability68
Accruals69
Owner Earnings Margin54
Sales growth19
Profit growth34
Reinvestment52
Price momentum57
Debt load23
Refinancing65
Debt Payback1
Liquidity28
Analyst ratings52
Opinion Changes50
Price Target Upside32
Market mood34
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Dong-A ST clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees29
Websitedonga-st.com
ISINKR7170900005
Last UpdateApr 2, 2026
Indices
KOSPI (South Korea)
Themes
CardiovascularRespiratoryPulmonologyUrologyOncology

Description

Analysis

Middle-of-the-road

Dong-A ST Co., Ltd. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is fragile. The company scores 8/20 on our value-creation score: creating some value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
11
2023202420252026

All-time high

55

Jan 2023

All-time low

11

Jun 2026

Average rank

36

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
78
89
81
80
Price/Earnings
45
47
37
45
Price/Book
70
85
69
69
Dividend Yield
1
42
40
45
Value (overall)
42
78
62
59

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Dong-A ST with its peers
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Handok
KSC:002390
15
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
CSPC Pharmaceutical
HKG:1093
79
CountryChina
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
Bukwang Pharmaceutical
KSC:003000
53
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kwangdong Pharmaceutical
KSC:009290
80
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Il Dong Pharmaceutical
KSC:249420
53
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →